SCHEMBL8798959

SCHEMBL8798959

COc1cc(Nc2cccc(C)c2)ncn1

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.58
TNNI3K Q59H18 4/20 0.56
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
ERBB3 P21860 4/20 0.52
KDR P35968 1/20 0.48
NPSR1 Q6W5P4 1/20 0.47
HTT P42858 1/20 0.47
HIF1A Q16665 1/20 0.47
THRB P10828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1387302 0.87 EGFR (0.72) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL3957924 0.85 EGFR (0.72) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL27523680 0.83 EGFR (0.54) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL28107893 0.82 MEN1 (0.62) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL27423215 0.81 MEN1 (0.49) EGFRMEN1KMT2ANPC1RAB9A
SCHEMBL8798667 0.81 EGFR (0.61) EGFRTNNI3KRAB9ANPSR1HTT
SCHEMBL2782010 0.81 EGFR (0.65) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL2279629 0.79 EGFR (0.59) EGFRTNNI3KNPC1ERBB3NPSR1
SCHEMBL690632 0.78 EGFR (0.62) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL7771269 0.78 EGFR (0.66) EGFRTNNI3KMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779888-A1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1997-06-25 EP disclosed
WO-1996007657-A1 PYRIMIDO[5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1996-03-14 WO disclosed